The number of patent sales in the 4Q 2016 remained about the same, but the median asking price of sellers of U.S. patents was higher
One of the leading public IP licensing companies, or PIPCOs, Tessera Holding Corporation, has changed its name to Xperi Corporation, an indication that it has
A few years ago a company whose patents were violated in China had little or no chance of defending its rights. Determined to move beyond
The PIPX public IP licensing company stock index soared to a 44.9% increase in 2016, led by an impressive 86.3% move for InterDigital. With a
There are abundant statistics on the cost of counterfeit goods, copyright infringement and even the negative impact of patent “trolls,” but nothing on the estimated
Many law firms still seek to participate in the outcome of clients’ patent litigation, but few are willing to share the cost of obtaining and
IP Dealmakers Forum is one of the more anticipated IP events of the year, especially for those engaged in patent licensing, sales, and M&A transactions.
Public IP licensing companies (PIPCOs) are very much alive and some company shares are doing surprisingly well, despite increased obstacles to patent licensing. PIPX
Can businesses and entrepreneurs compete with weaker U.S. patents in an innovation-driven global economy? An event featuring a broad range of IP thought-leaders on October
After a record-breaking first quarter, public IP company shares (PIPCOs) under-performed most stocks versus the S&P 500 index in the second quarter. Following a five-year
The US intellectual property system has been the envy of nations everywhere. Despite this, confusion reigns about what are patents and other IP rights, and
Cybersecurity firm Blue Coat Systems has decided to opt-out of an initial public offering and sell itself to software security leader Symantec for $4.65 billion.